Archives
Mental Health In Kidney Transplant Recipients
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Mental Health In Kidney Transplant Recipients
Background
Kidney transplantation offers patients with end-stage kidney (ESKD) disease freedom from frequent, time consuming, and uncomfortable dialysis treatments. However, successful outcomes are not ensured, and transplant recipients face new challenges, including concerns about transplant rejection and the need to adhere to a complex regimen of immunosuppressive therapy that may generate distressing side effects.1 Depression is a condition prevalent among patients with ESKD undergoing replacement therapy. It has also been increasingly recognized among kidney transplant recipients. It reduces self-esteem, leads to noncompliance with therapy, and eventually may lead to death.2
Did You Know?
- In 2022, more than 25,000 kidney transplants were performed in a single year with 5,863 coming from living donors3
- According to BDI, 22% – 39% of kidney transplant recipients reported depressive symptoms with 10% – 20% expressing moderate – severe depression1
- Depression is associated with several identifiable factors and a 2-fold greater risk of graft failure and death with a functioning graft.1
- Join us for this webinar to learn more about mental health in kidney transplant recipients and how it impacts patients, caregivers, graft survival, and mortality.
- The importance of mental health in kidney transplant recipients
- The impact of untreated depression in kidney transplant recipients
- Dobbels et al. American Journal of Kidney Diseases. Vol 51(5) 2008:819-828.
- Rocha G et al. Transplantation Proceedings. Vol 33 2001: 3424
- https://unos.org/news/in-focus/new-milestone-kidney-donation-and-transplant/
Fahad Aziz, MD
As a clinical nephrologist, Dr. Aziz cares for people living with a wide range of kidney diseases and disorders including renal transplant recipients. In addition to certification in the practice of internal medicine and nephrology, he holds Hypertension Specialist Certification from the American Society of Hypertension. Dr. Aziz is a member of the American College of Physicians, the American Society of Nephrology (ASN), and the American Society of Transplantation (AST). During his residency training, he was awarded “Best Resident of the Year” on two occasions. He has presented clinical research at national medical conferences at ASN and AST professional society scientific meetings. As a medical educator, he has provided classroom instruction topics in nephrology to physician assistant students and nephrology fellows as well as continuing medical education presentations to clinicians.
Lisa Voigt, PharmD, BCPS, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Senior Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
Jaimini Patel, PharmD, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jaimini Patel, PharmD, BCCCP, is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.
*Dr Fahad Aziz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Lisa Voigt & Jaimini Patel are employees of OPDC.
